PrecisemAb 碩準生技|最令人安心的抗體專家 PrecisemAb | A Pioneer of Anti-body Lock 我們的使命 精準的藥物,安心的治療 單株抗體藥物是現今主流的標靶治療選擇,能有效提升疾病治療效果,但傳統抗體藥物存在著全身性中和的風險,使患者產生嚴重副作用。 PrecisemAb 由 “Precise”與“mAb”組合而成,傳達我們透過「萬能抗體鎖」技術,使抗體能精準選擇疾病區域抗原,解決抗體全身性中和的問題,為病患打造最安心的治療選擇,推進人類健康福祉的企業使命。 企業簡介 PrecisemAb 由高雄醫學大學鄭添祿講座教授帶領團隊共同建立。 深耕抗體工程領域長達 25 年,鄭添祿教授成功研發獨步全球的「抗體鎖技術」,可有效提升抗體對疾病區域選擇性與降低抗體藥副作用,為抗體藥物安全性帶來革命性突破。 秉持著「以專業貢獻社會」的精神,鄭添祿教授將帶領團隊,持續為病患打造一個更安心的治療環境。 https://www.precisemab.com.tw https://en.www.precisemab.com.tw Our Mission Our name, PrecisemAb, is consisted of ‘‘Precise’’ and ‘‘mAb’’ which delivers our mission of enhancing antibody's safety through our Universal Antibody Lock technology. We deeply believe that ‘‘only when treatments are of both efficacy and safety would patients have the courage and persistance to fight for illness. ’’ We care about people's health, therefore we strive to create safer treatment solutions for patients. Universal Antibody Lock is just our first step...... Precise Antibody Drugs, Trustworthy Medical Treatments History PrecisemAb is established by Prof. Tien-Lu Cheng and his lab members. Prof. Cheng has cultivated in antibody engineering for 25 years and his original ‘‘Universal Antibody Lock’’ technology can effectively enhance antibody’s selectivity in disease area and reduce adverse effects caused by antibody drugs. This innovative technology is definitely a revolutionary breakthrough in biotechnology industry. Keeping the faith of ‘‘giving back to society with self professions’’ in mind, Prof. Cheng and PrecisemAb are committed to creating a safer and more trustworthy treatment environment for patients.
location_on
高雄市三民區十全1路100號第一教學大樓12樓1207室
call
07-3111577